Related by context. Frequent words. (Click for all words.) 82 MKC# 77 Initiates Phase II 74 includes investigational compounds 74 Commences Phase 74 Meets Primary Endpoint 74 phenylalanine ammonia lyase 73 investigational compounds 73 Tesetaxel 73 Initiate Phase 73 Daclizumab 73 PEG PAL PEGylated recombinant 73 Pivotal Phase III 73 Cetrorelix 73 Pivotal Phase 72 Panzem R 71 liposomal formulation 71 Initiates Phase 71 Completes Enrollment 71 GVAX R 71 Receives Orphan Drug Designation 70 refractory chronic lymphocytic 70 Epratuzumab 70 Sapacitabine 70 fibrosis IPF 70 proteasome inhibitor 70 R sorafenib tablets 70 TELINTRA 70 cutaneous T 70 Phase Ib IIa 70 multi kinase inhibitor 70 REGN# 70 Factor VIIa 70 elotuzumab 70 Presents Positive 70 Drug Candidate 70 epothilones 70 Golimumab 70 AEG# 69 Metastatic Melanoma 69 Dapagliflozin 69 inflammatory autoimmune diseases 69 phase IIb clinical 69 rheumatoid arthritis psoriatic arthritis 69 non alcoholic steatohepatitis 69 ALN TTR 69 histone deacetylase HDAC inhibitor 69 IMC #B 69 Epidermal Growth Factor Receptor 69 castrate resistant prostate cancer 69 BiTE R 68 Recombinant Human 68 Diamyd ® 68 MPS IVA 68 Belimumab 68 Ofatumumab 68 Eculizumab 68 forodesine 68 Dasatinib 68 Pivotal Study 68 GRNVAC1 68 HGS ETR2 68 TTR amyloidosis 68 hepatitis C lupus 68 Myelofibrosis 68 AVE# 68 Patient Enrollment 68 Clinical Trial Results 68 RGB # 68 TLR9 agonist 68 Pralatrexate 68 SAR# [004] 67 hepatitis C HCV 67 metastatic castration resistant 67 inhaled formulation 67 CEQ# 67 Nanobody 67 Phase III Clinical Trial 67 CYC# 67 PEG SN# 67 Copegus R 67 addressing idiopathic pulmonary 67 gets USFDA nod 67 Zolinza 67 6R BH4 67 topical anti infective 67 Allovectin 7 R 67 Inhalation Aerosol 67 FDA Accepts 67 JAK1 67 gastrointestinal mucositis 67 Pivotal Trial 67 PRT# 67 Traficet EN 67 Thiarabine 67 NEBIDO R 67 Phase Ib II 67 cancer immunotherapies 67 Study Evaluating 67 Diabetic Macular Edema 67 cardio renal 67 SIRT1 activators